Status:
COMPLETED
Corticoids in Severe Community-Acquired Pneumonia (CAP)
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
Community-Acquired Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to assess the efficacy of glucocorticoids as an adjuvant therapy in patients with severe community-acquired pneumonia (CAP) (Fine V). The hypothesis of the study is that g...
Detailed Description
Community acquired pneumonia (CAP) is associated with a local and systemic inflammatory response conducted by different pro and counter inflammatory cytokines. The evolution of the infection is mainly...
Eligibility Criteria
Inclusion
- Severe community-acquired pneumonia Fine V
- CRP \>=15 mg/100 mL
Exclusion
- Major contraindications for corticosteroids, such as uncontrolled diabetes, immunosuppression
- Previous glucocorticoid treatment during the previous month
- Documented extrapulmonary infection
- Previous hospitalization in the previous month
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00908713
Start Date
January 1 2004
End Date
March 1 2012
Last Update
March 20 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Servei Pneumologia. Hospital Clinic
Barcelona, Catalonia, Spain, 08036
2
Servei Pneumoloiga. Hospital Clinic
Barcelona, Catalonia, Spain, 08036
3
Hospital Clinic
Barcelona, Spain, 08036